Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

DA-9701: A New Multi-Acting Drug for the Treatment of Functional Dyspepsia

  • Received : 2012.12.07
  • Accepted : 2013.03.14
  • Published : 2013.05.31
Download PDF
⟨ Previous Next ⟩

Abstract

Motilitone$^{(R)}$ (DA-9701) is a new herbal drug that was launched for the treatment of functional dyspepsia in December 2011 in Korea. The heterogeneous symptom pattern and multiple causes of functional dyspepsia have resulted in multiple drug target strategies for its treatment. DA-9701, a compound consisting of a combination of Corydalis Tuber and Pharbitidis Semen, has being developed for treatment of functional dyspepsia. It has multiple mechanisms of action such as fundus relaxation, visceral analgesia, and prokinetic effects. Furthermore, it was found to significantly enhance meal-induced gastric accommodation and increase gastric compliance in dogs. DA-9701 also showed an analgesic effect in rats with colorectal distension induced visceral hypersensitivity and an antinociceptive effect in beagle dogs with gastric distension-induced nociception. The pharmacological effects of DA-9701 also include conventional effects, such as enhanced gastric emptying and gastrointestinal transit. The safety profile of DA-9701 is also preferable to that of other treatments.

Keywords

References

  1. Adsersen, A., Kjolbye, A., Dall, O. and Jager, A. K. (2007) Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Corydalis cava Schweigg. & Kort. J. Ethnopharmacol. 113, 179-182. https://doi.org/10.1016/j.jep.2007.05.006
  2. Agreus, L., Svardsudd, K., Nyren, O. and Tibblin, G. (1995) Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 109, 671-680. https://doi.org/10.1016/0016-5085(95)90373-9
  3. Al-Chaer, E. D., Kawasaki, M. and Pasricha, P. J. (2000) A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 119, 1276-1285. https://doi.org/10.1053/gast.2000.19576
  4. Azpiroz, F. and Malagelada, J. R. (1985) Physiological variations in canine gastric tone measured by an electronic barostat. Am. J. Physiol. 248, G229-237.
  5. Azpiroz, F. and Malagelada, J. R. (1986) Vagally mediated gastric relaxation induced by intestinal nutrients in the dog. Am. J. Physiol. 251, G727-735.
  6. Banani, S. J., Lankarani, K. B., Taghavi, A., Bagheri, M. H., Sefi dbakht, S. and Geramizadeh, B. (2008) Comparison of metoclopramide oral tablets and solution in treatment of dysmotility-like dyspepsia. Am. J. Health Syst. Pharm. 65, 1057-1061. https://doi.org/10.2146/ajhp070381
  7. Bisschops, R. and Tack, J. (2007) Dysaccommodation of the stomach: therapeutic nirvana? Neurogastroenterol. Motil. 19, 85-93. https://doi.org/10.1111/j.1365-2982.2006.00863.x
  8. Blackshaw, L. A., Grundy, D. and Scratcherd, T. (1987) Vagal afferent discharge from gastric mechanoreceptors during contraction and relaxation of the ferret corpus. J. Auton. Nerv. Syst. 18, 19-24. https://doi.org/10.1016/0165-1838(87)90130-5
  9. Boeckxstaens, G. E., Tytgat, G. N., Wajs, E., Van Nueten, L., De Ridder, F., Meulemans, A. and Tack, J. (2006) The infl uence of the novel 5-HT1A agonist R137696 on the proximal stomach function in healthy volunteers. Neurogastroenterol. Motil. 18, 919-926. https://doi.org/10.1111/j.1365-2982.2006.00812.x
  10. Bradesi, S., Herman, J. and Mayer, E. A. (2008) Visceral analgesics: drugs with a great potential in functional disorders? Curr. Opin. Pharmacol. 8, 697-703. https://doi.org/10.1016/j.coph.2008.08.009
  11. Brun, R. and Kuo, B. (2010) Functional dyspepsia. Therap. Adv. Gastroenterol. 3, 145-164. https://doi.org/10.1177/1756283X10362639
  12. Camilleri, M., Bueno, L., de Ponti, F., Fioramonti, J., Lydiard, R. B. and Tack, J. (2006) Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders. Gastroenterology 130, 1421-1434. https://doi.org/10.1053/j.gastro.2005.08.062
  13. Cannon, W. B. and Lieb, C. W. (1911) The receptive relaxation of the stomach. Am. J. Physiol. 29, 267-273.
  14. Cao, F. L., Shang, G. W., Wang, Y., Yang, F., Li, C. L. and Chen, J. (2011) Antinociceptive effects of intragastric dl-tetrahydropalmatine on visceral and somatic persistent nociception and pain hypersensitivity in rats. Pharmacol. Biochem. Behav. 100, 199-204. https://doi.org/10.1016/j.pbb.2011.08.016
  15. Choi, S., Choi, J. J., Jun, J. Y., Koh, J. W., Kim, S. H., Kim, D. H., Pyo, M. Y., Son, J. P., Lee, I., Son, M. and Jin, M. (2009) Induction of pacemaker currents by DA-9701, a prokinetic agent, in interstitial cells of Cajal from murine small intestine. Mol. Cells 27, 307-312. https://doi.org/10.1007/s10059-009-0039-6
  16. Choung, R. S., Talley, N. J., Peterson, J., Camilleri, M., Burton, D., Harmsen, W. S. and Zinsmeister, A. R. (2007) A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers. Neurogastroenteol. Motil. 19, 180-187. https://doi.org/10.1111/j.1365-2982.2006.00869.x
  17. Chung, E. K., Zhang, X., Li, Z., Zhang, H., Xu, H. and Bian, Z. (2007a) Neonatal maternal separation enhances central sensitivity to noxious colorectal distention in rat. Brain. Res. 1153, 68-77. https://doi.org/10.1016/j.brainres.2007.03.047
  18. Chung, E. K., Zhang, X. J., Xu, H. X., Sung, J. J. and Bian, Z. X. (2007b) Visceral hyperalgesia induced by neonatal maternal separation is associated with nerve growth factor-mediated central neuronal plasticity in rat spinal cord. Neuroscience 149, 685-695. https://doi.org/10.1016/j.neuroscience.2007.07.055
  19. Coffi n, B., Bouhassira, D., Chollet, R., Fraitag, B., De Meynard, C., Geneve, J., Lemann, M., Willer, J. C. and Jian, R. (1996) Effect of the kappa agonist fedotozine on perception of gastric distension in healthy humans. Aliment. Pharmacol. Ther. 10, 919-925. https://doi.org/10.1046/j.1365-2036.1996.109280000.x
  20. Coulie, B., Tack, J., Sifrim, D., Andrioli, A. and Janssens, J. (1999). Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of gastric fundus. Am. J. Physiol. 276, G373-377.
  21. Danzebrink, R. M. and Gebhart, G. F. (1990) Antinociceptive effects of intrathecal adrenoceptor agonists in a rat model of visceral nociception. J. Pharmacol. Exp. Ther. 253, 698-705.
  22. De Ponti, F., Crema, F., Moro, E., Nardelli, G., Frigo, G. and Crema, A. (2003) Role of 5-HT1B/D receptors in canine gastric accommodation: effect of sumatriptan and 5-HT1B/D receptor antagonists. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G96-104.
  23. Degen, L., Matzinger, D., Merz, M., Appel-Dingemanse, S., Osborne, S., Luchinger, S., Bertold, R., Maecke, H. and Beglinger, C. (2001) Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment. Pharmacol. Ther. 15, 1745-1751. https://doi.org/10.1046/j.1365-2036.2001.01103.x
  24. Degryse, H., De Schepper, A. and Verlinden, M. (1993) A double-blind fl uoroscopic study of cisapride on gastrointestinal motility in patients with functional dyspepsia. Scand. J. Gastroenterol. Suppl. 195, 1-4.
  25. Delvaux, M., Louvel, D., Mamet, J. P., Campos-Oriola, R. and Frexinos, J. (1998) Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome. Aliment. Pharmacol. Ther. 12, 849-855. https://doi.org/10.1046/j.1365-2036.1998.00375.x
  26. Ding, B., Zhou, T., Fan, G., Hong, Z. and Wu, Y. (2007) Qualitative and quantitative determination of ten alkaloids in traditional Chinese medicine Corydalis yanhusuo W.T. Wang by LC-MS/MS and LCDAD. J. Pharm. Biomed. Anal. 45, 219-226. https://doi.org/10.1016/j.jpba.2007.06.009
  27. Drossman, D. A. (1999) The functional gastrointestinal disorders and the Rome II process. Gut 45 Suppl. 2, II1-5. https://doi.org/10.1136/gut.45.2008.ii1
  28. Dukes, G. E., Talley, N. J., van Zanten, S. V., Heath, M., Sorrells, S. C., Perschy, T. B., Kleoudis, C. and Mangel, A. W. (2000) A doseranging, placebo-controlled, randomized clinical trial of alosetron, a 5-HT3 receptor antagonist, in the treatment of functional (nonulcer) dyspepsia. Am. J. Gastroenterol. 95, 2451.
  29. Dumitrascu, D. L., Ungureanu, O., Verzea, D. and Pascu, O. (1998) The effect of metoclopramide on antral emptying of a semisolid meal in patients with functional dyspepsia. A randomized placebo controlled sonographic study. Rom. J. Intern. Med. 36, 97-104.
  30. Dumuis, A., Sebben, M. and Bockaert, J. (1989) The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons. Naunyn Schmiedebergs Arch. Pharmacol. 340, 403-410. https://doi.org/10.1007/BF00167041
  31. Ejskjaer, N., Vestergaard, E. T., Hellstrom, P. M., Gormsen, L. C., Madsbad, S., Madsen, J. L., Jensen, T. A., Pezzullo, J. C., Christiansen, J. S., Shaughnessy, L. and Kosutic, G. (2009) Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis.Aliment. Pharmacol. Ther. 29, 1179-1187. https://doi.org/10.1111/j.1365-2036.2009.03986.x
  32. Galligan, J. J. and Burks, T. F. (1983) Centrally mediated inhibition of small intestinal transit and motility by morphine in the rat. J. Pharmacol. Exp. Ther. 226, 356-361.
  33. Gilja, O. H., Hausken, T., Bang, C. J. and Berstad, A. (1997) Effect of glyceryl trinitrate on gastric accommodation and symptoms in functional dyspepsia. Dig. Dis. Sci. 42, 2124-2131. https://doi.org/10.1023/A:1018839122354
  34. Graca, J. R., Leal, P. R., Gondim, F. A., Rola, F. H. and Santos, A. A. (2002) Variations in gastric compliance induced by acute blood volume changes in anesthetized rats. Braz. J. Med. Biol. Res. 35, 405-410. https://doi.org/10.1590/S0100-879X2002000300018
  35. Halder, S. L. and Talley, N. J. (2007) Functional Dyspepsia: A New Rome III Paradigm. Curr. Treat. Options Gastroenterol. 10, 259-272. https://doi.org/10.1007/s11938-007-0069-0
  36. Hallerback, B. I., Bommelaer, G., Bredberg, E., Campbell, M., Hellblom, M., Lauritsen, K., Wienbeck, M. and Holmgren, L. L. (2002) Dose fi nding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study. Aliment. Pharmacol. Ther. 16, 959-967. https://doi.org/10.1046/j.1365-2036.2002.01236.x
  37. Hancock, B. D., Bowen-Jones, E., Dixon, R., Dymock, I. W. and Cowley, D. J. (1974) The effect of metoclopramide on gastric emptying of solid meals. Gut 15, 462-467. https://doi.org/10.1136/gut.15.6.462
  38. Harada, Y., Nishioka, K., Kitahata, L. M., Kishikawa, K. and Collins, J. G. (1995) Visceral antinociceptive effects of spinal clonidine combined with morphine, [D-Pen2, D-Pen5] enkephalin, or U50,488H. Anesthesiology 83, 344-352. https://doi.org/10.1097/00000542-199508000-00015
  39. Herman, M. A., Niedringhaus, M., Alayan, A., Verbalis, J. G., Sahibzada, N. and Gillis, R. A. (2008) Characterization of noradrenergic transmission at the dorsal motor nucleus of the vagus involved in refl ex control of fundus tone. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R720-729. https://doi.org/10.1152/ajpregu.00630.2007
  40. Hirokawa, Y., Yamazaki, H., Yoshida, N. and Kato, S. (1998) A novel series of 6-methoxy-1H-benzotriazole-5-carboxamide derivatives with dual antiemetic and gastroprokinetic activities. Bioorg. Med. Chem. Lett. 8, 1973-1978. https://doi.org/10.1016/S0960-894X(98)00341-2
  41. Houghton, L. A., Cremonini, F., Camilleri, M., Busciglio, I., Fell, C., Cox, V., Alpers, D. H., Dewit, O. E., Dukes, G. E., Gray, E., Lea, R., Zinsmeister, A. R. and Whorwell, P. J. (2007) Effect of the NK(3) receptor antagonist, talnetant, on rectal sensory function and compliance in healthy humans. Neurogastroenterol. Motil. 19, 732-743. https://doi.org/10.1111/j.1365-2982.2007.00934.x
  42. Jahnberg, T., Martinson, J., Hulten, L. and Fasth, S. (1975) Dynamic gastric response to expansion before and after vagotomy. Scand. J. Gastroenterol. 10, 593-598.
  43. Janssen, P., Tack, J., Sifrim, D., Meulemans, A. L. and Lefebvre, R. A. (2004) Infl uence of 5-HT1 receptor agonists on feline stomach relaxation. Eur. J. Pharmacol. 492, 259-267. https://doi.org/10.1016/j.ejphar.2004.03.054
  44. Jia, W., Wang, X., Xu, D., Zhao, A. and Zhang, Y. (2006) Common traditional Chinese medicinal herbs for dysmenorrhea. Phytother. Res. 20, 819-824. https://doi.org/10.1002/ptr.1905
  45. Jung, Y. S., Kim, M. Y., Lee, H. S., Park, S. L. and Lee, K. J. (2013) Effect of DA-9701, a novel prokinetic agent, on stress-induced delayed gastric emptying and hormonal changes in rats. Neurogastroenterol. Motil. 25, 254-259. https://doi.org/10.1111/nmo.12053
  46. Kamigauchi, M. and Iwasa, K. (1994) Corydalis spp.: in vitro culture and the biotransformation of protoberberines. Biotechnol. Agric. For. 26, 93-105.
  47. Kanaizumi, T., Nakano, H., Matsui, Y., Ishikawa, H., Shimizu, R., Park, S. and Kuriya, N. (1991) Prokinetic effect of AS-4370 on gastric emptying in healthy adults. Eur. J. Clin. Pharmacol. 41, 335-337. https://doi.org/10.1007/BF00314963
  48. Kessler, R. M., Ansari, M. S., de Paulis, T., Schmidt, D. E., Clanton, J. A., Smith, H. E., Manning, R. G., Gillespie, D. and Ebert, M. H. (1991) High affi nity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides. J. Nucl. Med. 32, 1593-1600.
  49. Kim, E. R., Min, B. H., Lee, S. O., Lee, T. H., Son, M. and Rhee, P. L. (2012) Effects of DA-9701, a novel prokinetic agent, on gastric accommodation in conscious dogs. J. Gastroenterol. Hepatol. 27, 766-772. https://doi.org/10.1111/j.1440-1746.2011.06924.x
  50. Kim, Y. S., Lee, M. Y., Choi, E. s., Oh, J. T., Sohn, Y. W., Oh, Y. L., Ryu, H. S., Seo, G. S. and Choi, S. C. (2010) W1406 DA-9701, a new prokinetic agent, improves feeding inhibition by restraint stress in rats-comparative study with in vivo micro-animal. Gastroenterology 138, S-717.
  51. Kuiken, S. D., Tytgat, G. N. and Boeckxstaens, G. E. (2005) Review article: drugs interfering with visceral sensitivity for the treatment of functional gastrointestinal disorders--the clinical evidence. Aliment. Pharmacol. Ther. 21, 633-651. https://doi.org/10.1111/j.1365-2036.2005.02392.x
  52. Kumar, S., Kumar, D., Singh, J., Narender, R. and Kaushik, D. (2009) Anti-infl ammatory, Analgesic and Antioxidant Activities of Ipomoea hederaceae Linn. Planta Med. 75, P-100.
  53. Lee, T. H., Choi, J. J., Kim, D. H., Choi, S., Lee, K. R., Son, M. and Jin, M. (2008) Gastroprokinetic effects of DA-9701, a new prokinetic agent formulated with Pharbitis Semen and Corydalis Tuber. Phytomedicine 15, 836-843. https://doi.org/10.1016/j.phymed.2008.02.019
  54. Lee, T. H., Kim, K. H., Lee, S. O., Lee, K. R., Son, M. and Jin, M. (2011) Tetrahydroberberine, an isoquinoline alkaloid isolated from corydalis tuber, enhances gastrointestinal motor function. J. Pharmacol. Exp. Ther. 338, 917-924. https://doi.org/10.1124/jpet.111.182048
  55. Lei, Y., Zhu, H., Xing, J. and Chen, J. D. (2005) Rectal distension modulates canine gastric tone and accommodation. Dig. Dis. Sci. 50, 2134-2140. https://doi.org/10.1007/s10620-005-3020-z
  56. Lidow, M. S. (2002) Long-term effects of neonatal pain on nociceptive systems. Pain 99, 377-383. https://doi.org/10.1016/S0304-3959(02)00258-0
  57. Lim, H. C., Park, H., Lee, S. I., Jahng, J. and Lee, Y. J. (2012) Tu1985 effects of DA-9701, a novel prokinetic agent on gastric motor function in guinea pig. Gastroenterology 142, S893-S894.
  58. Lin, C. and Al-Chaer, E. D. (2003) Long-term sensitization of primary afferents in adult rats exposed to neonatal colon pain. Brain Res. 971, 73-82. https://doi.org/10.1016/S0006-8993(03)02358-8
  59. Ma, Z. Z., Xu, W., Jensen, N. H., Roth, B. L., Liu-Chen, L. Y. and Lee, D. Y. (2008) Isoquinoline alkaloids isolated from Corydalis yanhusuo and their binding affi nities at the dopamine D1 receptor. Molecules 13, 2303-2312. https://doi.org/10.3390/molecules13092303
  60. Mackie, A. D., Ferrington, C., Cowan, S., Merrick, M. V., Baird, J. D. and Palmer, K. R. (1991) The effects of renzapride, a novel prokinetic agent, in diabetic gastroparesis. Aliment. Pharmacol. Ther. 5, 135-142.
  61. Madsen, J. L. and Fuglsang, S. (2008) A randomized, placebo-controlled, crossover, double-blind trial of the NK1 receptor antagonist aprepitant on gastrointestinal motor function in healthy humans. Aliment. Pharmacol. Ther. 27, 609-615. https://doi.org/10.1111/j.1365-2036.2008.03618.x
  62. Mansi, C., Borro, P., Giacomini, M., Biagini, R., Mele, M. R., Pandolfo, N. and Savarino, V. (2000) Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. Aliment Pharmacol. Ther. 14, 561-569. https://doi.org/10.1046/j.1365-2036.2000.00742.x
  63. Matsueda, K., Hongo, M., Tack, J., Saito, Y. and Kato, H. (2012) A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut 61, 821-828. https://doi.org/10.1136/gutjnl-2011-301454
  64. Mayer, E. A., Bradesi, S., Chang, L., Spiegel, B. M., Bueller, J. A. and Naliboff, B. D. (2008) Functional GI disorders: from animal models to drug development. Gut 57, 384-404. https://doi.org/10.1136/gut.2006.101675
  65. Mayer, E. A. and Gebhart, G. F. (1994) Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 107, 271-293.
  66. Mayrand, S., Tremblay, L. and Diamant, N. (1994) In vivo measurement of feline esophageal tone. Am. J. Physiol. 267, G914-921.
  67. McCallum, R. W. and Cynshi, O. (2007a) Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study. Aliment. Pharmacol. Ther. 26, 1121-1130. https://doi.org/10.1111/j.1365-2036.2007.03461.x
  68. McCallum, R. W. and Cynshi, O. (2007b) Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi-center, placebo-controlled trial. Aliment. Pharmacol. Ther. 26, 107-116. https://doi.org/10.1111/j.1365-2036.2007.03346.x
  69. Miller, M. S., Galligan, J. J. and Burks, T. F. (1981) Accurate measurement of intestinal transit in the rat. J. Pharmacol. Methods 6, 211-217. https://doi.org/10.1016/0160-5402(81)90110-8
  70. Monroe, M. J., Hornby, P. J. and Partosoedarso, E. R. (2004) Central vagal stimulation evokes gastric volume changes in mice: a novel technique using a miniaturized barostat. Neurogastroenterol. Motil. 16, 5-11. https://doi.org/10.1046/j.1365-2982.2003.00464.x
  71. Moro, E., Crema, F., De Ponti, F. and Frigo, G. (2004) Triptans and gastric accommodation: pharmacological and therapeutic aspects. Dig. Liver Dis. 36, 85-92. https://doi.org/10.1016/j.dld.2003.09.012
  72. Mundt, M. W., Hausken, T. and Samsom, M. (2002) Effect of intragastric barostat bag on proximal and distal gastric accommodation in response to liquid meal. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G681-686.
  73. Nagahata, Y., Urakawa, T., Kuroda, H., Tomonaga, K., Idei, H., Kawakita, N., Yoshizumi, K. and Saitoh, Y. (1992) The effect of dopamine on rat gastric motility. Gastroenterol. Jpn. 27, 482-487.
  74. Noh, Y. W., Jung, H. K., Kim, S. E. and Jung, S. A. (2010) Overlap of erosive and non-erosive refl ux diseases with functional gastrointestinal disorders according to Rome III criteria. J. Neurogastroenterol. Motil. 16, 148-156. https://doi.org/10.5056/jnm.2010.16.2.148
  75. Piessevaux, H., De Winter, B., Louis, E., Muls, V., De Looze, D., Pelckmans, P., Deltenre, M., Urbain, D. and Tack, J. (2009) Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol. Motil. 21, 378-388. https://doi.org/10.1111/j.1365-2982.2009.01262.x
  76. Ramsbottom, N. and Hunt, J. N. (1970) Studies of the effect of metoclopramide and apomorphine on gastric emptying and secretion in man. Gut 11, 989-993. https://doi.org/10.1136/gut.11.12.989
  77. Read, N. W., Abitbol, J. L., Bardhan, K. D., Whorwell, P. J. and Fraitag, B. (1997) Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut 41, 664-668. https://doi.org/10.1136/gut.41.5.664
  78. Rhie, S. Y., Choi, C. H., Lee, H. W., Do, M. Y., Lee, S. H., Han, S. P, et al. (2007) The frequency of functional dyspepsia subtypes and its related factors for health check up subjects. Korean. J. Neurogastroenterol. Motil. 13, 31-37.
  79. Romer, M., Painsipp, E., Schwetz, I. and Holzer, P. (2005) Facilitation of gastric compliance and cardiovascular reaction by repeated isobaric distension of the rat stomach. Neurogastroenterol. Motil. 17, 399-409. https://doi.org/10.1111/j.1365-2982.2005.00649.x
  80. Rosch, W., Liebregts, T., Gundermann, K. J., Vinson, B. and Holtmann, G. (2006) Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5. Phytomedicine 13 Suppl 5, 114-121. https://doi.org/10.1016/j.phymed.2006.03.022
  81. Sarnelli, G., Sifrim, D., Janssens, J. and Tack, J. (2004) Influence of sildenafi l on gastric sensorimotor function in humans. Am. J. Physiol Gastrointest. Liver Physiol. 287, G988-992. https://doi.org/10.1152/ajpgi.00419.2003
  82. Schemann, M., Michel, K., Zeller, F., Hohenester, B. and Ruhl, A. (2006) Region-specific effects of STW 5 (Iberogast) and its components in gastric fundus, corpus and antrum. Phytomedicine 13 Suppl 5, 90-99. https://doi.org/10.1016/j.phymed.2006.03.020
  83. Sekino, Y., Yamada, E., Sakai, E., Ohkubo, H., Higurashi, T., Iida, H., Endo, H., Takahashi, H., Koide, T., Sakamoto, Y., Nonaka, T., Gotoh, E., Maeda, S., Nakajima, A. and Inamori, M. (2012) Influence of sumatriptan on gastric accommodation and on antral contraction in healthy subjects assessed by ultrasonography. Nuerogastroenterol. Motil. 24, 1083-e1564. https://doi.org/10.1111/j.1365-2982.2012.01984.x
  84. Soji, Y., Kadokawa, T., Masuda, Y., Kawashima, K. and Nakamura, K. (1969) Effects of Corydalis alkaloid upon inhibition of gastric juice secretion and prevention of gastric ulcer in experimental animals. Nihon Yakurigaku Zasshi 65, 196-209. https://doi.org/10.1254/fpj.65.196
  85. Stanghellini, V., De Giorgio, R., Barbara, G., Cogliandro, R., Tosetti, C., De Ponti, F. and Corinaldesi, R. (2004) Delayed gastric emptying in functional dyspepsia. Curr. Treat. Options Gastroenterol. 7, 259-264. https://doi.org/10.1007/s11938-004-0011-7
  86. Stanghellini, V., De Ponti, F., De Giorgio, R., Barbara, G., Tosetti, C. and Corinaldesi, R. (2003) New developments in the treatment of functional dyspepsia. Drugs 63, 869-892. https://doi.org/10.2165/00003495-200363090-00003
  87. Stevens, J. E., Russo, A., Maddox, A. F., Rayner, C. K., Phillips, L., Talley, N. J., Giguere, M., Horowitz, M. and Jones, K. L. (2008) Effect of itopride on gastric emptying in longstanding diabetes mellitus. Neurogastroenterol. Motil. 20, 456-463. https://doi.org/10.1111/j.1365-2982.2007.01058.x
  88. Suzuki, H., Nishizawa, T. and Hibi, T. (2006) Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classifi cation. J. Gastroenterol. 41, 513-523. https://doi.org/10.1007/s00535-006-1847-5
  89. Tack, J. (2008) Prokinetics and fundic relaxants in upper functional GI disorders. Curr. Opin. Pharmacol. 8, 690-696. https://doi.org/10.1016/j.coph.2008.09.009
  90. Tack, J. (2009) Mandatory and optional function tests in gastroduodenal disorders. Best Pract. Res. Clin. Gastroenterol. 23, 387-393. https://doi.org/10.1016/j.bpg.2009.04.004
  91. Tack, J., Broeckaert, D., Coulie, B. and Janssens, J. (1998a) The infl uence of cisapride on gastric tone and the perception of gastric distension. Aliment. Pharmacol. Ther. 12, 761-766. https://doi.org/10.1046/j.1365-2036.1998.00366.x
  92. Tack, J., Broekaert, D., Coulie, B., Fischler, B. and Janssens, J. (2003a) Infl uence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans. Aliment. Pharmacol. Ther. 17, 603-608. https://doi.org/10.1046/j.1365-2036.2003.01469.x
  93. Tack, J., Caenepeel, P., Corsetti, M. and Janssens, J. (2004) Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention. Gastroenterology 127, 1058-1066. https://doi.org/10.1053/j.gastro.2004.07.005
  94. Tack, J., Caenepeel, P., Fischler, B., Piessevaux, H. and Janssens, J. (2001) Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 121, 526-535. https://doi.org/10.1053/gast.2001.27180
  95. Tack, J. and Janssen, P. (2011a) Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia. Expert Opin. Investig. Drugs 20, 701-712. https://doi.org/10.1517/13543784.2011.562890
  96. Tack, J. and Janssen, P. (2011b) Emerging drugs for functional dyspepsia. Expert Opin. Emerg. Drugs 16, 283-292. https://doi.org/10.1517/14728214.2011.558502
  97. Tack, J., Masclee, A., Heading, R., Berstad, A., Piessevaux, H., Popiela, T., Vandenberghe, A. and Kato, H. (2009a) A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia. Neurogastroenterol. Motil. 21, 272-280. https://doi.org/10.1111/j.1365-2982.2009.01261.x
  98. Tack, J., Piessevaux, H., Coulie, B., Caenepeel, P. and Janssens, J. (1998b) Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 115, 1346-1352. https://doi.org/10.1016/S0016-5085(98)70012-5
  99. Tack, J., Talley, N. J., Camilleri, M., Holtmann, G., Hu, P., Malagelada, J. R. and Stanghellini, V. (2006) Functional gastroduodenal disorders. Gastroenterology 130, 1466-1479. https://doi.org/10.1053/j.gastro.2005.11.059
  100. Tack, J., Van Den Elzen, B., Tytgat, G., Wajs, E., Van Nueten, L., De Ridder, F. and Boeckxstaens, G. (2009b) A placebo-controlled trial of the 5-HT1A agonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia. Neurogastroenterol. Motil. 21, 619-626. https://doi.org/10.1111/j.1365-2982.2008.01260.x
  101. Tack, J., Vos, R., Janssens, J., Salter, J., Jauffret, S. and Vandeplassche, G. (2003b) Infl uence of tegaserod on proximal gastric tone and on the perception of gastric distension. Aliment. Pharmacol. Ther. 18, 1031-1037. https://doi.org/10.1046/j.1365-2036.2003.01775.x
  102. Talley, N. J., Camilleri, M., Burton, D., Thomforde, G., Koch, K., Rucker, M. J., Peterson, J., Zinsmeister, A. R. and Earnest, D. L. (2006) Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers. Aliment. Pharmacol. Ther. 24, 859-867. https://doi.org/10.1111/j.1365-2036.2006.03049.x
  103. Talley, N. J., Locke, G. R., 3rd, Herrick, L. M., Silvernail, V. M., Prather, C. M., Lacy, B. E., DiBaise, J. K., Howden, C. W., Brenner, D. M., Bouras, E. P., El-Serag, H. B., Abraham, B. P., Moayyedi, P. and Zinsmeister, A. R. (2012) Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemp. Clin. Trials 33, 523-533. https://doi.org/10.1016/j.cct.2012.02.002
  104. Talley, N. J., Tack, J., Ptak, T., Gupta, R. and Giguere, M. (2008) Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut 57, 740-746. https://doi.org/10.1136/gut.2007.132449
  105. Talley, N. J., Zinsmeister, A. R., Schleck, C. D. and Melton, L. J. 3rd (1992) Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 102, 1259-1268.
  106. Tanila, H., Kauppila, T. and Taira, T. (1993) Inhibition of intestinal motility and reversal of postlaparotomy ileus by selective alpha 2-adrenergic drugs in the rat. Gastroenterology 104, 819-824.
  107. Taniyama, K., Nakayama, S., Takeda, K., Matsuyama, S., Shirakawa, J., Sano, I. and Tanaka, C. (1991) Cisapride stimulates motility of the intestine via the 5-hydroxytryptamine receptors. J. Pharmacol. Exp. Ther. 258, 1098-1104.
  108. Thumshirn, M., Camilleri, M., Choi, M. G. and Zinsmeister, A. R. (1999) Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology 116, 573-585. https://doi.org/10.1016/S0016-5085(99)70179-4
  109. Tomita, T., Okugawa, T., Yamasaki, T., Kondo, T., Toyoshima, F., Sakurai, J., Oshima, T., Fukui, H., Daimon, T., Watari, J., Kashiwagi, T., Matsumoto, T. and Miwa, H. (2013) Use of scintigraphy to evaluate gastric accommodation and emptying: comparison with barostat. J. Gastroenterol. Hepatol. 28, 106-111. https://doi.org/10.1111/j.1440-1746.2012.07261.x
  110. Van Oudenhove, L., Kindt, S., Vos, R., Coulie, B. and Tack, J. (2008) Influence of buspirone on gastric sensorimotor function in man. Aliment. Pharmacol. Ther. 28, 1326-1333. https://doi.org/10.1111/j.1365-2036.2008.03849.x
  111. Veldhuyzen van Zanten, S. J., Jones, M. J., Verlinden, M. and Talley, N. J. (2001) Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am. J. Gastroenterol 96, 689-696. https://doi.org/10.1016/S0002-9270(00)02314-5
  112. Wang, C., Wang, S., Fan, G. and Zou, H. (2010) Screening of antinociceptive components in Corydalis yanhusuo W.T. Wang by comprehensive two-dimensional liquid chromatography/tandem mass spectrometry. Anal. Bioanal. Chem. 396, 1731-1740. https://doi.org/10.1007/s00216-009-3409-1
  113. Wang, S. and Mo, W. Y. (1989) Effect of intraseptal noradrenaline on somatic and visceral pain threshold of rabbits. Sheng Li Xue Bao 41, 128-135.
  114. Williams, P. D., Colbert, W. E., Shetler, T. J. and Turk, J. A. (1992) Comparative pharmacological profi le of muscarinic agonists in the isolated ileum, the pithed rat, and the mouse charcoal meal transit test. Gen. Pharmacol. 23, 177-185. https://doi.org/10.1016/0306-3623(92)90006-6
  115. Yin, J., Ouyang, H. and Chen, J. D. (2007) Potential of intestinal electrical stimulation for obesity: a preliminary canine study. Obesity (Silver Spring) 15, 1133-1138. https://doi.org/10.1038/oby.2007.615
  116. Zhao, J., Liao, D. and Gregersen, H. (2005) Tension and stress in the rat and rabbit stomach are location- and direction-dependent. Neurogastroenterol. Motil. 17, 388-398. https://doi.org/10.1111/j.1365-2982.2004.00635.x

Cited by

  1. Pharmacokinetics of chlorogenic acid and corydaline in DA-9701, a new botanical gastroprokinetic agent, in rats vol.44, pp.7, 2014, https://doi.org/10.3109/00498254.2013.874610
  2. Effect of DA-9701 on Gastric Motor Function Assessed by Magnetic Resonance Imaging in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Trial vol.10, pp.9, 2015, https://doi.org/10.1371/journal.pone.0138927
  3. Effect of DA-9701 on the Normal Motility and Clonidine-induced Hypomotility of the Gastric Antrum in Rats vol.22, pp.2, 2016, https://doi.org/10.5056/jnm15131
  4. The Evidence of DA-9701 on Bowel Motility vol.23, pp.2, 2017, https://doi.org/10.5056/jnm17011
  5. Efficacy and Safety of New Prokinetic Agent Benachio Q Solution® in Patients with Postprandial Distress Syndrome Subtype in Functional Dyspepsia: A Single-center, Randomized, Double-blind, Placebo-controlled Pilot Study vol.66, pp.1, 2015, https://doi.org/10.4166/kjg.2015.66.1.17
  6. Pharmacokinetics and Brain Distribution of Tetrahydropalmatine and Tetrahydroberberine after Oral Administration of DA-9701, a New Botanical Gastroprokinetic Agent, in Rats vol.38, pp.2, 2015, https://doi.org/10.1248/bpb.b14-00678
  7. Effect of DA-9701, a Novel Prokinetic Agent, on Post-operative Ileus in Rats vol.23, pp.1, 2017, https://doi.org/10.5056/jnm16003
  8. Cardiovascular Autonomic Dysfunction in Patients with Drug-Induced Parkinsonism vol.13, pp.1, 2017, https://doi.org/10.3988/jcn.2017.13.1.15
  9. Gender differences in corydaline pharmacokinetics in rats vol.45, pp.5, 2015, https://doi.org/10.3109/00498254.2014.988772
  10. Emerging drugs for functional dyspepsia vol.20, pp.2, 2015, https://doi.org/10.1517/14728214.2015.1009827
  11. Efficacy of DA-9701 (Motilitone) in Functional Dyspepsia Compared to Pantoprazole: A Multicenter, Randomized, Double-blind, Non-inferiority Study vol.22, pp.2, 2016, https://doi.org/10.5056/jnm15178
  12. DA-9701 improves colonic transit time and symptoms in patients with functional constipation: A prospective study vol.32, pp.12, 2017, https://doi.org/10.1111/jgh.13807
  13. Effect of DA-9701 on Feeding Inhibition Induced by Acute Restraint Stress in Rats vol.18, pp.1, 2018, https://doi.org/10.7704/kjhugr.2018.18.1.50
  14. DA-9701 (Motilitone): A Multi-Targeting Botanical Drug for the Treatment of Functional Dyspepsia vol.19, pp.12, 2013, https://doi.org/10.3390/ijms19124035
  15. The Efficacy and Safety of GCWB104 ( Flos Lonicera Extract) in Functional Dyspepsia: A Single-Center, Randomized, Double-Blind, Placebo-Controlled Study vol.14, pp.1, 2013, https://doi.org/10.5009/gnl19283
  16. Effect of DA-9701 on the Gastrointestinal Motility in the Streptozotocin-Induced Diabetic Mice vol.10, pp.22, 2013, https://doi.org/10.3390/jcm10225282